Task: Answer Verification
Input (English): Question: Is breslow density a novel prognostic feature in cutaneous malignant melanoma?
Answer: We show a proof of concept that the BD represents a novel morphological prognostic biomarker that is independent of the BT, and that there is potential to combine these into a Breslow score. Larger studies are needed to validate the BD, but the simplicity of this biomarker makes it a strong candidate for translation to clinical practice.
Output (English): yes